{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:19:36Z","timestamp":1759335576977},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1097\/mao.0b013e3181be6af4","type":"journal-article","created":{"date-parts":[[2009,11,20]],"date-time":"2009-11-20T14:38:26Z","timestamp":1258727906000},"page":"1131-1137","source":"Crossref","is-referenced-by-count":13,"title":["TNF-\u03b1 Receptor Expression Correlates With Histologic Activity of Otosclerosis"],"prefix":"10.1097","volume":"30","author":[{"given":"P\u00e9ter","family":"Csomor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Istv\u00e1n","family":"Sziklai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tam\u00e1s","family":"Karosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20-20210212","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/00129492-200103000-00023","article-title":"Patophysiology of otosclerosis.","volume":"22","author":"Chole","year":"2001","journal-title":"Otol Neurotol"},{"key":"R3-20-20210212","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3109\/00313028409067908","article-title":"Histopathology of the stapes in otosclerosis.","volume":"16","author":"Iyer","year":"1984","journal-title":"Pathology"},{"key":"R4-20-20210212","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.amjoto.2005.11.001","article-title":"Otosclerosis: etiopathogenesis and histopathology.","volume":"27","author":"Cureoglu","year":"2006","journal-title":"Am J Otolaryngol"},{"key":"R5-20-20210212","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3109\/00016489609137910","article-title":"Measles virus in otosclerosis and the specific immune response of the inner ear.","volume":"116","author":"Arnold","year":"1996","journal-title":"Acta Otolaryngol (Stockh)"},{"key":"R6-20-20210212","first-page":"827","article-title":"Polymerase chain reaction amplification of measles virus sequence from human temporal bone sections with active otosclerosis.","volume":"17","author":"McKenna","year":"1996","journal-title":"Am J Otol"},{"key":"R7-20-20210212","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00129492-200407000-00009","article-title":"Measles virus prevalence in otosclerotic stapes footplate samples.","volume":"25","author":"Karosi","year":"2004","journal-title":"Otol Neurotol"},{"key":"R8-20-20210212","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1097\/01.mlg.0000225928.35838.e5","article-title":"Detection of osteoprotegerin and TNF-alpha mRNA in ankylotic stapes footplates in connection with measles virus positivity.","volume":"116","author":"Karosi","year":"2006","journal-title":"Laryngoscope"},{"key":"R9-20-20210212","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/01.MLG.0000165462.35495.DF","article-title":"Codetection of measles virus and tumor necrosis factor- mRNA in otosclerotic stapes footplates.","volume":"115","author":"Karosi","year":"2005","journal-title":"Laryngoscope"},{"key":"R10-20-20210212","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000058757","article-title":"TNF in the inflammatory response.","volume":"74","author":"Mannel","year":"2000","journal-title":"Chem Immunol"},{"key":"R11-20-20210212","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1073\/pnas.95.2.570","article-title":"The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor.","volume":"95","author":"Grell","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R12-20-20210212","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0960-9822(93)90009-D","article-title":"Emerging families of cytokines and receptors.","volume":"3","author":"Bazan","year":"1993","journal-title":"Curr Biol"},{"key":"R13-20-20210212","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0092-8674(01)00237-9","article-title":"The TNF and TNF receptor superfamilies: integrating mammalian biology.","volume":"104","author":"Locksley","year":"2001","journal-title":"Cell"},{"key":"R14-20-20210212","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.cdd.4401189","article-title":"Tumor necrosis factor signaling.","volume":"10","author":"Wajant","year":"2003","journal-title":"Cell Death Differ"},{"key":"R15-20-20210212","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1126\/science.1071924","article-title":"TNF-R1 signaling: a beautiful pathway.","volume":"296","author":"Chen","year":"2002","journal-title":"Science"},{"key":"R16-20-20210212","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0092-8674(88)90486-2","article-title":"A novel form of TNF\/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF.","volume":"53","author":"Kriegler","year":"1988","journal-title":"Cell"},{"key":"R17-20-20210212","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.1432-1327.1998.2540439.x","article-title":"Apoptosis signaling by death receptors.","volume":"254","author":"Schulze-Osthoff","year":"1998","journal-title":"Eur J Biochem"},{"key":"R18-20-20210212","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1097\/01.mlg.0000227251.67251.1f","article-title":"Activated osteoclasts with CD51\/61 expression in otosclerosis.","volume":"116","author":"Karosi","year":"2006","journal-title":"Laryngoscope"},{"key":"R19-20-20210212","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/00002281-200105000-00003","article-title":"Anti-tumor necrosis factor therapies.","volume":"13","author":"Taylor","year":"2001","journal-title":"Curr Opin Rheumatol"},{"key":"R20-20-20210212","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1097\/00005537-200209000-00019","article-title":"Tumor necrosis factor-, an initiator, and etanercept, an inhibitor of cochlear inflammation.","volume":"112","author":"Satoh","year":"2002","journal-title":"Laryngoscope"},{"key":"R21-20-20210212","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/01.mao.0000185082.28598.87","article-title":"Etanercept treatment for autoimmune inner ear disease: results of a pilot placebo-controlled study.","volume":"26","author":"Cohen","year":"2005","journal-title":"Otol Neurotol"},{"key":"R22-20-20210212","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1017\/S0022215106002593","article-title":"Etanercept, a tumour necrosis factor receptor antagonist, and methotrexate in acute sensorineural hearing loss.","volume":"120","author":"Street","year":"2006","journal-title":"J Laryngol Otol"},{"key":"R23-20-20210212","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0378-5955(96)00027-5","article-title":"Human otosclerotic bone-derived peptide decreases the gain of the electromotility in isolated outer hair cells.","volume":"95","author":"Sziklai","year":"1996","journal-title":"Hear Res"},{"key":"R24-20-20210212","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00129492-200301000-00012","article-title":"Blockage of immune-mediated inner ear damage by etanercept.","volume":"24","author":"Wang","year":"2003","journal-title":"Otol Neurotol"},{"key":"R25-20-20210212","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1159\/000095897","article-title":"Local perfusion of the tumor necrosis factor blocker infliximab to inner ear improves autoimmune neurosensory hearing loss.","volume":"11","author":"Van Wijk","year":"2006","journal-title":"Audiol Neurootol"},{"key":"R26-20-20210212","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/01.mlg.0000191466.09210.9a","article-title":"Osteoprotegrin knockout mice demonstrate abnormal remodeling of the otic capsule and progressive hearing loss.","volume":"116","author":"Zehnder","year":"2006","journal-title":"Laryngoscope"},{"key":"R27-20-20210212","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cytogfr.2004.06.004","article-title":"The molecular triad OPG\/RANK\/RANKL: involvement in the orchestration of pathophysiological bone remodelling.","volume":"15","author":"Theoleyre","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"key":"R28-20-20210212","first-page":"92","article-title":"Medical treatment of otosclerosis: rationale for use of bisphosphonates.","volume":"14","author":"Brookler","year":"2008","journal-title":"Int Tinnitus J"},{"key":"R30-20-20210212","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S8756-3282(02)00679-8","article-title":"Otosclerosis: a genetically heterogeneous disease involving at least three different genes.","volume":"30","author":"Van Den Bogaert","year":"2002","journal-title":"Bone"}],"container-title":["Otology & Neurotology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MAO.0b013e3181be6af4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:45:14Z","timestamp":1620960314000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00129492-200912000-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mao.0b013e3181be6af4","relation":{},"ISSN":["1531-7129"],"issn-type":[{"value":"1531-7129","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}